Does LIFITEGRAST Cause Product packaging issue? 56 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Product packaging issue have been filed in association with LIFITEGRAST (Xiidra). This represents 0.4% of all adverse event reports for LIFITEGRAST.
56
Reports of Product packaging issue with LIFITEGRAST
0.4%
of all LIFITEGRAST reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging issue From LIFITEGRAST?
Of the 56 reports.
Is Product packaging issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LIFITEGRAST. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does LIFITEGRAST Cause?
Eye irritation (2,486)
Vision blurred (2,465)
Drug ineffective (1,373)
Instillation site pain (1,281)
Dysgeusia (1,067)
Eye pain (1,032)
Instillation site reaction (1,019)
Dry eye (1,013)
Ocular hyperaemia (570)
Lacrimation increased (547)
What Other Drugs Cause Product packaging issue?
ACETAMINOPHEN (448)
LOPERAMIDE (351)
DIMETHICONE\LOPERAMIDE (348)
USTEKINUMAB (221)
FENTANYL (200)
MINOXIDIL (173)
CETIRIZINE (166)
ESTRADIOL (163)
GOLIMUMAB (95)
CYCLOSPORINE (93)
Which LIFITEGRAST Alternatives Have Lower Product packaging issue Risk?
LIFITEGRAST vs LIMAPROST
LIFITEGRAST vs LINACLOTIDE
LIFITEGRAST vs LINAGLIPTIN
LIFITEGRAST vs LINAGLIPTIN\METFORMIN
LIFITEGRAST vs LINCOMYCIN